CD16 Expression on Monocytes in Healthy Individuals but Not Schistosome-Infected Patients Is Positively Associated with Levels of Parasite-Specific IgG and IgG1

PLoS Neglected Tropical Diseases

Volumn 8, Issue 8, 2014, Pages

  Appleby, Laura J ^a   Nausch, Norman ^a   Erskine, Louise ^a   Bourke, Claire D ^a   Rujeni, Nadine ^a   Midzi, Nicholas ^b   Mduluza, Takafira ^c   Mutapi, Francisca ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c UNIVERSITY OF ZIMBABWE   (Zimbabwe)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; CD14 ANTIGEN; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; HELMINTH ANTIBODY;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ARTICLE; CHILD; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNE RESPONSE; IMMUNOASSAY; MALE; MONOCYTE; PHENOTYPE; PREVALENCE; QUESTIONNAIRE; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS; SEROLOGY; ADOLESCENT; ADULT; ANIMAL; BLOOD; IMMUNOLOGY; PRESCHOOL CHILD; SCHISTOSOMIASIS HAEMATOBIA;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES, HELMINTH; ANTIGENS, CD14; CHILD; CHILD, PRESCHOOL; GPI-LINKED PROTEINS; HUMANS; IMMUNOGLOBULIN G; MALE; MONOCYTES; RECEPTORS, IGG; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA;

EID: 84934785447     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0003049     Document Type: Article

References (62)

1. WHO (2012) WHA65.21 Elimination of schistosomiasis. Geneva: World Health Organization.
2. WHO (2002) Prevention and control of schistosomiasis and soil-transmitted helminthiasis: report of a WHO expert committee. Geneva, Switzerland: WHO.
3. WHO (2006) Preventative Chemotherapy in Helminthiasis: coordinated use of antihelminthic drugs in control interventions: a manual for health professionals and programme managers. Geneva: World Health Organization.
4. Kupferschmidt K, (2013) A Worm Vaccine, Coming at a Snail's Pace. Science 339: 502–503.
5. Woolhouse M, Taylor P, Matanhire D, Chandiwana S, (1991) Acquired immunity and epidemiology of Schistosoma haematobium. Nature 351: 757–759.
6. Loke Pn, Gallagher I, Nair MG, Zang X, Brombacher F, et al. (2007) Alternative Activation Is an Innate Response to Injury That Requires CD4+ T Cells to be Sustained during Chronic Infection. J Immunol 179: 3926–3936.
7. Wynn TA, Barron L, (2010) Macrophages: master regulators of inflammation and fibrosis. Seminars in liver disease 30: 245–257.
8. Nair M, Du Y, Perrigoue J, Zaph C, Taylor J, et al. (2009) Alternatively activated macrophage-derived RELM-α is a negative regulator of type 2 inflammation in the lung. The Journal of Experimental Medicine 206: 937.
9. Pesce JT, Ramalingam TR, Mentink-Kane MM, Wilson MS, El Kasmi KC, et al. (2009) Arginase-1-expressing macrophages suppress Th2 cytokine-driven inflammation and fibrosis. PLoS Pathog 5: e1000371.
10. Bronte V, Serafini P, Mazzoni A, Segal DM, Zanovello P, (2003) L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends in Immunology 24: 302–306.
11. Ellner JJ, Mahmoud AAF, (1979) Killing of Schistosomula of Schistosoma mansoni by Normal Human Monocytes. The Journal of Immunology 123: 949–951.
12. Olds GR, Ellner JJ, el-Kholy A, Mahmoud AA, (1981) Monocyte-mediated killing of schistosomula of Schistosoma mansoni: alterations in human Schistosomiasis mansoni and tuberculosis. The Journal of Immunology 127: 1538–1542.
13. Xu X, Remold HG, Caulfield JP, (1993) Potential role for scavenger receptors of human monocytes in the killing of Schistosoma mansoni. The American journal of pathology 142: 685–689.
14. van de Winkel JGJ, Capel PJA, (1993) Human IgG Fc receptor heterogeneity: molecular aspects and clinical implications. Immunology Today 14: 215–221.
15. Zawada AM, Rogacev KS, Rotter Br, Winter P, Marell R-R, et al. (2011) SuperSAGE evidence for CD14++CD16+ monocytes as a third monocyte subset. Blood 118: e50–e61.
16. Wong KL, Yeap WH, Tai JJ, Ong SM, Dang TM, et al. (2012) The three human monocyte subsets: implications for health and disease. Immunol Res 53: 41–57.
17. Gessner JE, Heiken H, Tamm A, Schmidt RE, (1998) The IgG Fc receptor family. Annals of Hematology 76: 231–248.
18. Hazenbos WLW, Heijnen IAFM, Meyer D, Hofhuis FMA, Renardel de Lavalette C, et al. (1998) Murine IgG1 Complexes Trigger Immune Effector Functions Predominantly via FcγRIII (CD16). The Journal of Immunology 161: 3026–3032.
19. Jankovic D, Cheever AW, Kullberg MC, Wynn TA, Yap G, et al. (1998) CD4+ T Cell–mediated Granulomatous Pathology in Schistosomiasis Is Downregulated by a B Cell–dependent Mechanism Requiring Fc Receptor Signaling. The Journal of Experimental Medicine 187: 619–629.
20. Mutapi F, Ndhlovu PD, Hagan P, Woolhouse ME, (1997) A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection. Parasite Immunol 19: 255–263.
21. Khalife J, Dunne DW, Richardson BA, Mazza G, Thorne KJ, et al. (1989) Functional role of human IgG subclasses in eosinophil-mediated killing of schistosomula of Schistosoma mansoni. The Journal of Immunology 142: 4422–4427.
22. Mutapi F, Mduluza T, Gomez-Escobar N, Gregory WF, Fernandez C, et al. (2006) Immuno-epidemiology of human Schistosoma haematobium infection: Preferential lgG3 antibody responsiveness to a recombinant antigen dependent on age and parasite burden. BMC Infectious Diseases 6: 96.
23. Hotez P, Bethony J, Diemert D, Pearson M, Loukas A (2011) Developing Vaccines to Combat Hookworm Infection and Intestinal Schistosomiasis. The Causes and Impacts of Neglected Tropical and Zoonotic Diseases: Opportunities for Integrated Intervention Strategies. Washington D.C.: National Academies Press.
24. Mitchell KM, Mutapi F, Savill NJ, Woolhouse ME, (2012) Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms. Proc Natl Acad Sci U S A 109: 13347–13352.
25. Mutapi F, Burchmore R, Foucher A, Harcus Y, Nicoll G, et al. (2005) Praziquantel treatment of people exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens. Journal of Infectious Diseases 192: 1108–1118.
26. Mutapi F, Burchmore R, Mduluza T, Midzi N, Turner CM, et al. (2008) Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population. J Infect Dis 198: 167–175.
27. Joseph S, Jones FM, Walter K, Fulford AJ, Kimani G, et al. (2004) Increases in human T helper 2 cytokine responses to Schistosoma mansoni worm and worm-tegument antigens are induced by treatment with praziquantel. Journal of Infectious Diseases 190: 835–842.
28. Appleby LJ, Nausch N, Midzi N, Mduluza T, Allen JE, et al. (2013) Sources of heterogeneity in human monocyte subsets. Immunology Letters 152: 32–41.
29. Midzi N, Sangweme D, Zinyowera S, Mapingure MP, Brouwer KC, et al. (2008) The burden of polyparasitism among primary schoolchildren in rural and farming areas in Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene 102: 1039–1045.
30. Mott K, (1983) A reusable polyamide filter for diagnosis of S. haematobium infection by urine filtration. Bull Soc Pathol Exot Filiales 76: 101–104.
31. Katz N, Chaves A, Pellegrino J, (1972) A simple device for quantitative stool thick smear technique in schistosomiasis mansoni. Revista do Instituto de Medicina Tropical de Sao Paulo 14: 397–400.
32. Knight WB, Hiatt RA, Cline BL, Ritchie LS, (1976) A Modification of the Formol-Ether Concentration Technique for Increased Sensitivity in Detecting Schistosoma Mansoni Eggs. The American Journal of Tropical Medicine and Hygiene 25: 818–823.
33. Nausch N, Louis D, Lantz O, Peguillet I, Trottein F, et al. (2012) Age-related patterns in human myeloid dendritic cell populations in people exposed to Schistosoma haematobium infection. PLoS Neglected Tropical Diseases 6: e1824.
34. Abeles RD, McPhail MJ, Sowter D, Antoniades CG, Vergis N, et al. (2012) CD14, CD16 and HLA-DR reliably identifies human monocytes and their subsets in the context of pathologically reduced HLA-DR expression by CD14(hi)/CD16(neg) monocytes: Expansion of CD14(hi)/CD16(pos) and contraction of CD14(lo)/CD16(pos) monocytes in acute liver failure. Cytometry Part A : the journal of the International Society for Analytical Cytology 81: 823–834.
35. Anderson RM, May RM (1991) Infectious diseases of humans : dynamics and control/Roy M. Anderson and Robert M. May: Oxford: Oxford University Press, 1991.
36. Chandiwana SK, Woolhouse MEJ, (1991) Heterogeneities in water contact patterns and the epidemiology of Schistosoma haematobium. Parasitology 103: 363–370.
37. Mutapi F, Roddam A, (2002) p-values for pathogens: statistical inference from infectious-disease data. Lancet Infect Dis 2: 219–230.
38. Nyugen J, Agrawal S, Gollapudi S, Gupta S, (2010) Impaired functions of peripheral blood monocyte subpopulations in aged humans. J Clin Immunol 30: 806–813.
39. Seidler S, Zimmermann HW, Bartneck M, Trautwein C, Tacke F, (2010) Age-dependent alterations of monocyte subsets and monocyte-related chemokine pathways in healthy adults. BMC Immunology 11: 30.
40. Fingerle G, Pforte A, Passlick B, Blumenstein M, Strobel M, et al. (1993) The novel subset of CD14+/CD16+ blood monocytes is expanded in sepsis patients. Blood 82: 3170–3176.
41. Hagan P, Blumenthal UJ, Dunn D, Simpson AJG, Wilkins HA, (1991) Human IgE, IgG4 and resistance to reinfection with Schistosoma haematobium. Nature 349: 243–245.
42. Capron A, Dessaint JP, (1992) Immunologic aspects of schistosomiasis. Annual review of medicine 43: 209–218.
43. Mutapi F, Ndhlovu P, Hagan P, Spicer J, Mduluza T, et al. (1998) Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection. Journal of Infectious Diseases 178: 289–293.
44. Turner JD, Bourke CD, Meurs L, Mbow M, Dièye TN, et al. (2014) Circulating CD14brightCD16+ ‘Intermediate’ Monocytes Exhibit Enhanced Parasite Pattern Recognition in Human Helminth Infection. PLoS Negl Trop Dis 8: e2817.
45. Mutapi F, Bourke C, Harcus Y, Midzi N, Mduluza T, et al. (2011) Differential recognition patterns of Schistosoma haematobium adult worm antigens by the human antibodies IgA, IgE, IgG1 and IgG4. Parasite Immunology 33: 181–192.
46. Boctor FN, Peter JB, (1990) IgG subclasses in human chronic schistosomiasis: over-production of schistosome-specific and non-specific IgG4. Clinical and experimental immunology 82: 574–578.
47. Caldas IR, Correa-Oliveira R, Colosimo E, Carvalho OS, Massara CL, et al. (2000) Susceptibility and resistance to Schistosoma mansoni reinfection: parallel cellular and isotypic immunologic assessment. The American Journal of Tropical Medicine and Hygiene 62: 57–64.
48. Black CL, Mwinzi PN, Muok EM, Abudho B, Fitzsimmons CM, et al. (2010) Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni. PLoS Neglected Tropical Diseases 4: e637.
49. Appleby LJ, Nausch N, Bourke CD, Rujeni N, Midzi N, et al. (2012) Chitinase 3-like 1 protein levels are elevated in Schistosoma haematobium infected children. PLoS Neglected Tropical Diseases 6: e1898.
50. Zheng M, Cai WM, Zhao JK, Zhu SM, Liu RH, (2005) Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value. Acta Trop 96: 148–152.
51. Jankovic D, Wynn TA, Kullberg MC, Hieny S, Caspar P, et al. (1999) Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms. Journal of Immunology 162: 345–351.
52. Clarkson SB, Ory PA, (1988) CD16. Developmentally regulated IgG Fc receptors on cultured human monocytes. The Journal of Experimental Medicine 167: 408–420.
53. Ziegler-Heitbrock HW, Ulevitch RJ, (1993) CD14: cell surface receptor and differentiation marker. Immunology Today 14: 121–125.
54. Landmann R, Knopf HP, Link S, Sansano S, Schumann R, et al. (1996) Human monocyte CD14 is upregulated by lipopolysaccharide. Infection and Immunity 64: 1762–1769.
55. King CH, (2007) Lifting the burden of schistosomiasis–defining elements of infection-associated disease and the benefits of antiparasite treatment. J Infect Dis 196: 653–655.
56. Kramski M, Schorcht A, Johnston AP, Lichtfuss GF, Jegaskanda S, et al. (2012) Role of monocytes in mediating HIV-specific antibody-dependent cellular cytotoxicity. Journal of immunological methods 384: 51–61.
57. Webster NL, Kedzierska K, Azzam R, Paukovics G, Wilson J, et al. (2006) Phagocytosis stimulates mobilization and shedding of intracellular CD16A in human monocytes and macrophages: inhibition by HIV-1 infection. Journal of Leukocyte Biology 79: 294–302.
58. Isa MB, Martinez L, Giordano M, Passeggi C, de Wolff MC, et al. (2002) Comparison of immunoglobulin G subclass profiles induced by measles virus in vaccinated and naturally infected individuals. Clinical and diagnostic laboratory immunology 9: 693–697.
59. Woolhouse M, Hagan P, (1999) Seeking the ghost of worms past. Nature Medicine 5: 1225–1227.
60. Drescher B, Witte T, Schmidt RE, (2003) Glycosylation of FcγRIII in N163 as mechanism of regulating receptor affinity. Immunology 110: 335–340.
61. Ravetch JV, Bolland S, (2001) IgG Fc receptors. Annu Rev Immunol 19: 275–290.
62. Li J, Pritchard DK, Wang X, Park DR, Bumgarner RE, et al. (2007) cDNA microarray analysis reveals fundamental differences in the expression profiles of primary human monocytes, monocyte-derived macrophages, and alveolar macrophages. J Leukoc Biol 81: 328–335.